{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-062618","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.891590+00:00","generated_at":"2026-06-01T22:07:57.315833+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Applied DNA Sciences receives Nasdaq equity deficiency notice; equity negative $175K","bullets":["As of March 31, 2024, stockholders' equity was negative $175,385, below the $2.5M minimum for Nasdaq Capital Market.","Company must submit a compliance plan by July 1, 2024 to regain compliance with Nasdaq Listing Rule 5550(b)(1).","Nasdaq may grant up to 180-day extension if plan accepted; no guarantee of acceptance or eventual compliance.","Letter has no immediate effect on listing; company is evaluating options."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-062618","json":"https://secwatch.observer/filing/0001104659-24-062618.json","markdown":"https://secwatch.observer/filing/0001104659-24-062618.md","text":"https://secwatch.observer/filing/0001104659-24-062618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/0001104659-24-062618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/tm2414775d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:07:57.315833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b9ab22f57176952755aece47b2fae7887d01865","claim":"BNB PLUS CORP. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"(the “Stockholders’ Equity Requirement”). In the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, the Company reported stockholders’ equity of ($175,385), which was below the Stockholders’ Equity Requirement. In accordance with Nasdaq rules, the Company has 45 calendar days, or until July 1, 2024, to submit a plan to the Staff to","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/0001104659-24-062618-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}